Life-threatening allergic responses to food are an increasingly important public health problem. It is estimated that two children in every classroom now have a food allergy that requires strict dietary avoidance. Children with allergies, and their caretakers, often deal with reduced quality of life from the fear that an accidental exposure will trigger a life-threatening anaphylactic response. Food allergies are also closely linked to other diseases such as eczema, asthma, and allergic rhinitis. ClostraBio was formed with a passion for treating these diseases.
ClostraBio’s world-leading scientific team has made key discoveries that highlight the importance of the intestinal microbiota in regulating allergic sensitization to food. Our company is committed to a deeper understanding of the role of intestinal microbes in gut barrier function and determining the mechanisms of barrier protection. We are breaking new ground in treatments that restore this protective intestinal barrier function in individuals where it is compromised.